Aldesleukin in Patients With Metastatic Renal Cell Carcinoma and Metastatic Melanoma



Status:Archived
Conditions:Skin Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Open-label Pharmacokinetic Trial of Aldesleukin (Rh-Interleukin-2 [IL-2]) Administered Intravenously to Subjects With Metastatic Renal Cell Carcinoma and Metastatic Melanoma With Immunologic Correlative Studies


This study will evaluate the pharmacokinetics of aldesleukin in patients with metastatic
renal cell cancer and metastatic melanoma



We found this trial at
4
sites
Darien Pediatric Associates
106 Noroton Ave
Darien, Connecticut 06820
(203) 655-9741
Darien Pediatric Associates Our office is pleased and privileged to care for your children and...
?
mi
from
Darien, CT
Click here to add this to my saved trials
University of Colorado Cancer Center - Anschutz Cancer Pavilion
13001 E. 17th Pl.
Aurora, Colorado 80045
303-724-5000
University of Colorado Cancer Center - Anschutz Cancer Pavilion The University of Colorado Denver |...
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Norris Comprehensive Cancer Center
Los Angeles, California 90033
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
James Graham Brown Cancer Center
529 S Jackson St
Louisville, Kentucky 40202
(502) 562-4369
James Graham Brown Cancer Center No one should feel compelled to leave Kentucky to seek...
?
mi
from
Louisville, KY
Click here to add this to my saved trials